131 related articles for article (PubMed ID: 18408222)
1. Neutrophil role in in vivo anti-lymphoma activity of rituximab: FCGR3B-NA1/NA2 polymorphism does not influence response and survival after rituximab treatment.
Cartron G; Ohresser M; Salles G; Solal-Céligny P; Colombat P; Watier H
Ann Oncol; 2008 Aug; 19(8):1485-1487. PubMed ID: 18408222
[TBL] [Abstract][Full Text] [Related]
2. Variations in genes encoding neutrophil antigens NA1 and NA2.
Matsuo K; Procter J; Stroncek D
Transfusion; 2000 Jun; 40(6):645-53. PubMed ID: 10864983
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.
Cartron G; Dacheux L; Salles G; Solal-Celigny P; Bardos P; Colombat P; Watier H
Blood; 2002 Feb; 99(3):754-8. PubMed ID: 11806974
[TBL] [Abstract][Full Text] [Related]
4. NA1/NA2 heterozygote of Fcgr3b is a risk factor for progression of IgA nephropathy in Chinese.
Xu G; He Q; Shou Z; Wang H; Zhang X; Wang Y; Chen Y; Chen J
J Clin Lab Anal; 2007; 21(5):298-302. PubMed ID: 17847104
[TBL] [Abstract][Full Text] [Related]
5. Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients.
Mahmoud I; Moalla M; Ben Tekaya A; Bouden S; Rouached L; Tekaya R; Saidane O; Gorji Y; Elleuch M; Laatar A; Hamdi W; Abdelmoula L; Sfar I
Drug Metab Pers Ther; 2023 Jun; 38(2):155-162. PubMed ID: 36919284
[TBL] [Abstract][Full Text] [Related]
6. FCGR3 variants and expression of human neutrophil antigen-1a, -1b, and -1c in the populations of northern Germany and Uganda.
Flesch BK; Doose S; Siebert R; Ntambi E; Neppert J
Transfusion; 2002 Apr; 42(4):469-75. PubMed ID: 12076295
[TBL] [Abstract][Full Text] [Related]
7. The expression of NA antigens in people with unusual Fcgamma receptor III genotypes.
Matsuo K; Procter JL; Chanock S; Stroncek DF
Transfusion; 2001 Jun; 41(6):775-82. PubMed ID: 11399819
[TBL] [Abstract][Full Text] [Related]
8. Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus.
Morris DL; Roberts AL; Witherden AS; Tarzi R; Barros P; Whittaker JC; Cook TH; Aitman TJ; Vyse TJ
Eur J Hum Genet; 2010 Sep; 18(9):1027-31. PubMed ID: 20442749
[TBL] [Abstract][Full Text] [Related]
9. Distribution of FcgammaRIIa and FcgammaRIIIb genotypes in patients with generalized aggressive periodontitis.
de Souza RC; Colombo AP
J Periodontol; 2006 Jul; 77(7):1120-8. PubMed ID: 16805673
[TBL] [Abstract][Full Text] [Related]
10. Fc γ receptor IIIB (FcγRIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.
Adu B; Dodoo D; Adukpo S; Hedley PL; Arthur FK; Gerds TA; Larsen SO; Christiansen M; Theisen M
PLoS One; 2012; 7(9):e46197. PubMed ID: 23049979
[TBL] [Abstract][Full Text] [Related]
11. NA1/NA2 antisera inhibit FcgammaRI- but not FcgammaRII- mediated phagocytosis.
Flesch BK; Maass W; Neppert J
Vox Sang; 1998; 75(3):247-52. PubMed ID: 9852415
[TBL] [Abstract][Full Text] [Related]
12. FcgammaRIIIB polymorphism: evidence that NA1/NA2 and SH are located in two closely linked loci and that the SH allele is linked to the NA1 allele in the Danish population.
Steffensen R; Gülen T; Varming K; Jersild C
Transfusion; 1999 Jun; 39(6):593-8. PubMed ID: 10378839
[TBL] [Abstract][Full Text] [Related]
13. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16).
Huizinga TW; Kleijer M; Tetteroo PA; Roos D; von dem Borne AE
Blood; 1990 Jan; 75(1):213-7. PubMed ID: 2136803
[TBL] [Abstract][Full Text] [Related]
14. The association between fcgammaRIIIB polymorphisms and systemic lupus erythematosus in Korea.
Hong CH; Lee JS; Lee HS; Bae SC; Yoo DH
Lupus; 2005; 14(5):346-50. PubMed ID: 15934433
[TBL] [Abstract][Full Text] [Related]
15. Haplotypes of FcγRIIa and FcγRIIIb polymorphic variants influence IgG-mediated responses in neutrophils.
van der Heijden J; Nagelkerke S; Zhao X; Geissler J; Rispens T; van den Berg TK; Kuijpers TW
J Immunol; 2014 Mar; 192(6):2715-21. PubMed ID: 24554771
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of FcγRIIIB-NA1/NA2 Polymorphism in Visceral Leishmaniasis.
Abasi M; Lotfi P; Bazmani A; Matini M; Hajilooi M
Iran Red Crescent Med J; 2014 Apr; 16(4):e12437. PubMed ID: 24910789
[TBL] [Abstract][Full Text] [Related]
17. Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD16 antigen.
Stroncek DF; Skubitz KM; Plachta LB; Shankar RA; Clay ME; Herman J; Fleit HB; McCullough J
Blood; 1991 Apr; 77(7):1572-80. PubMed ID: 1826224
[TBL] [Abstract][Full Text] [Related]
18. Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.
Salmon JE; Edberg JC; Kimberly RP
J Clin Invest; 1990 Apr; 85(4):1287-95. PubMed ID: 1690757
[TBL] [Abstract][Full Text] [Related]
19. Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis.
Bournazos S; Bournazou I; Murchison JT; Wallace WA; McFarlane P; Hirani N; Simpson AJ; Dransfield I; Hart SP
Lung; 2010 Dec; 188(6):475-81. PubMed ID: 20924590
[TBL] [Abstract][Full Text] [Related]
20. HNA-1d: a new human neutrophil antigen located on Fcγ receptor IIIb associated with neonatal immune neutropenia.
Reil A; Sachs UJ; Siahanidou T; Flesch BK; Bux J
Transfusion; 2013 Oct; 53(10):2145-51. PubMed ID: 23347194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
